Ledger.Open graph →
SEC Form D · filed May 24, 2013

Kite Pharma, Inc

Offering
$16.4M
Sold
$16.4M
Exemption
Industry
Biotechnology
Location
Los Angeles, CA
Type

People & firms on this filing (15)

David Bonderman · Los Angeles, CADirectorJoshua A. Kazam · Los Angeles, CADirectorArie S. Belldegrun · Los Angeles, CADirectorRoy Doumani · Los Angeles, CADirectorAya Jakobovits · Los Angeles, CAExec · DirectorSteven B. Ruchefsky · Los Angeles, CADirectorFarah Champsi · Los Angeles, CADirectorSteven C. Quay · SEATTLE, WAExec · DirectorChristopher Benjamin · SEATTLE, WADirectorShu-Chih Chen · SEATTLE, WADirectorJohn Barnhart · SEATTLE, WADirectorJames Safka · MENLO PARK, CADirectorBill Whipple · Valley City, NDDirectorFarah Champsi · San Carlos, CADirectorRan Nussbaum · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗